Published in Jpn J Cancer Res on November 01, 2002
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies. Mol Diagn Ther (2013) 1.23
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol (2012) 1.12
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma. Br J Cancer (2013) 1.02
Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas. Br J Cancer (2004) 0.95
HER2 expression in cervical cancer as a potential therapeutic target. BMC Cancer (2004) 0.94
EGFR/HER-targeted therapeutics in ovarian cancer. Future Med Chem (2012) 0.90
Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423. PLoS One (2014) 0.86
Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Int J Clin Exp Pathol (2013) 0.86
Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells. J Exp Clin Cancer Res (2010) 0.82
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. Cancer Cell Int (2015) 0.79
The target therapy of ovarian clear cell carcinoma. Onco Targets Ther (2014) 0.79
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma. Oncol Lett (2015) 0.78
Monoclonal antibodies in gynecological cancer: a critical point of view. Clin Dev Immunol (2011) 0.78
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet (2009) 6.65
Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Circulation (2012) 3.53
Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol (2006) 3.01
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol (2011) 2.79
Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development (2009) 2.26
High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol (2005) 2.25
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J (2013) 2.19
Transradial cardiac catheterization: a review of access site complications. Catheter Cardiovasc Interv (2011) 2.13
Transradial coronary intervention using a novel 5-Fr sheathless guiding catheter. Catheter Cardiovasc Interv (2009) 2.07
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer. World J Surg (2009) 2.02
Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis. Hum Pathol (2004) 1.77
100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci (2010) 1.76
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. Cancer Sci (2010) 1.72
Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. J Anesth (2011) 1.67
Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab (2004) 1.63
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen. Eur Urol (2007) 1.56
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat (2011) 1.55
Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab (2004) 1.55
Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res (2011) 1.54
The role of the immune system in preeclampsia. Mol Aspects Med (2007) 1.54
Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheter Cardiovasc Interv (2011) 1.54
Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem (2011) 1.54
A prospective multicenter registry of 0.010-inch guidewire and compatible system for chronic total occlusion: the PIKACHU registry. Catheter Cardiovasc Interv (2010) 1.54
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
Progress in the retrograde approach for chronic total coronary artery occlusion: a case with successful angioplasty using CART and reverse-anchoring techniques 3 years after failed PCI via a retrograde approach. Catheter Cardiovasc Interv (2008) 1.52
Percutaneous coronary intervention using a virtual 3-Fr guiding catheter. Catheter Cardiovasc Interv (2010) 1.52
Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem (2010) 1.50
New method to increase a backup support of a 6 French guiding coronary catheter. Catheter Cardiovasc Interv (2004) 1.47
Feasibility and safety of 7F sheathless guiding catheter during transradial coronary intervention. Catheter Cardiovasc Interv (2012) 1.47
A unique complication of the retrograde approach in angioplasty for chronic total occlusion of the coronary artery. Catheter Cardiovasc Interv (2008) 1.45
Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can J Anaesth (2006) 1.45
The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J Reprod Immunol (2006) 1.44
Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions. Catheter Cardiovasc Interv (2014) 1.44
Coronary intervention with 4-French catheters. Catheter Cardiovasc Interv (2010) 1.44
Outcomes of primary percutaneous coronary intervention for acute myocardial infarction with unprotected left main coronary artery occlusion. Catheter Cardiovasc Interv (2012) 1.42
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. Circ J (2014) 1.42
Slow rewarming has no effects on the decrease in jugular venous oxygen hemoglobin saturation and long-term cognitive outcome in diabetic patients. Anesth Analg (2002) 1.42
A novel method of PercuSurge distal protection in a five French guiding catheter without an Export aspiration catheter. J Invasive Cardiol (2008) 1.42
Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors. Anesthesiology (2014) 1.42
Prehospital Transfer Pathway and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention. Circ J (2015) 1.39
A new 0.010-inch guidewire and compatible balloon catheter system: the IKATEN registry. Catheter Cardiovasc Interv (2009) 1.39
The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes. Obstet Gynecol (2003) 1.38
Renal artery intervention using a virtual 4.5-Fr guiding catheter. Catheter Cardiovasc Interv (2012) 1.38
The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg (2002) 1.37
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program. Catheter Cardiovasc Interv (2015) 1.37
Long-term outcome of acute myocardial infarction patients treated with stents versus balloon angioplasty: results from randomized trials. Int J Cardiol (2008) 1.37
Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev (2009) 1.32
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet (2011) 1.31
The discovery of pyridalyl: a novel insecticidal agent for controlling lepidopterous pests. Pest Manag Sci (2004) 1.28
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci (2007) 1.27
Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol (2010) 1.27
Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol (2005) 1.26
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
ASIAN: a web server for inferring a regulatory network framework from gene expression profiles. Nucleic Acids Res (2005) 1.25
Th1/Th2 balance in preeclampsia. J Reprod Immunol (2003) 1.25
Effect of the Fukushima nuclear power plant accident on radioiodine (¹³¹ I) content in human breast milk. J Obstet Gynaecol Res (2012) 1.24
Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet (2006) 1.21
Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer (2008) 1.21
Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol (2007) 1.20
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol (2014) 1.18
Inner experience of pain: imagination of pain while viewing images showing painful events forms subjective pain representation in human brain. Cereb Cortex (2006) 1.16
IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod (2006) 1.14
p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology (2008) 1.14
Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem Biophys Res Commun (2006) 1.14
CD4(+)CD25high regulatory T cells in human pregnancy. J Reprod Immunol (2005) 1.13
NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia (2011) 1.13
Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol (2009) 1.13
Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway. Cancer Res (2010) 1.11
A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505). Jpn J Clin Oncol (2009) 1.11
Photodynamic therapy for cervical intraepithelial neoplasia. Oncology (2005) 1.10
Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia. Stroke (2003) 1.10
Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology (2008) 1.10
The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Anesth Analg (2005) 1.10
Advanced malignant solitary fibrous tumor in pelvis responding to radiation therapy. Pathol Int (2007) 1.08
Survival of parvovirus B19-infected cells by cellular autophagy. Virology (2006) 1.08
Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence. J Biol Chem (2007) 1.08
Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol (2010) 1.07
Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer. Int J Gynecol Cancer (2010) 1.06
Tracheal intubation with the PENTAX-AWS (airway scope) reduces changes of hemodynamic responses and bispectral index scores compared with the Macintosh laryngoscope. J Neurosurg Anesthesiol (2009) 1.06
Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab (2006) 1.06
Physician-patient communication and patient satisfaction in Japanese cancer consultations. Soc Sci Med (2002) 1.06
Molecular phylogeny and expression of poplar circadian clock genes, LHY1 and LHY2. New Phytol (2009) 1.05
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy. Med Oncol (2008) 1.05
Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev Cell (2012) 1.05
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment? J Exp Clin Cancer Res (2012) 1.04
Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology (2007) 1.04
Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients. Hum Pathol (2004) 1.03
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. Int J Clin Oncol (2009) 1.03
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer (2009) 1.02
PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol (2005) 1.01
The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia. Endocr J (2003) 1.01
Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary. Oncol Rep (2006) 1.01
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Support Care Cancer (2012) 1.00
Cadmium exposure and trace elements in human breast milk. Toxicology (2003) 0.99
Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials. J Immunother (2005) 0.99